Notice NOT-MD-20-015 from the NIH Guide for Grants and Contracts

Internal stakeholders may include Clinical Pharmacologists, Biomarker & Bioinformatics scientists, Clinical Specimen Coordinators, Clinical Project Managers and…
From Seattle Genetics, Inc. - Wed, 25 Mar 2020 00:17:12 GMT - View all Bothell, WA jobs

Notice NOT-DA-20-037 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-21-005 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support projects that further develop or exploit advances using in situ or in vivo imaging or related technologies to investigate HIV/SIV infection, latent reservoirs, the pathogenic consequences of HIV/SIV infection, or the effects of HIV/SIV or substance use disorder (SUD) therapies. Applicants may propose primate or human studies to investigate blood, lymphoid, or brain tissues.

Notice NOT-ES-20-012 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-758 from the NIH Guide for Grants and Contracts

Notice NOT-EB-20-004 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-20-146 from the NIH Guide for Grants and Contracts. The NIDA Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot, feasibility, or small clinical trials with medications, behavioral interventions, immunotherapies, therapeutic devices, therapeutic digital applications, health services, prevention interventions, biomarkers, and development of research methodology. This Funding Opportunity Announcement requires that a clinical trial be proposed. The proposed project must be related to the programmatic interests of NIDA.

Competitive Salary: EMBL: Coordinator, Phenomics Data Location: Cambridge, Cambridgeshire, England

Notice NOT-TR-20-011 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-043 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-079 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-20-145 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.

Funding Opportunity PA-20-144 from the NIH Guide for Grants and Contracts. This FOA solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches, and intervention efficacy or effectiveness trials. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.

Funding Opportunity RFA-HG-20-002 from the NIH Guide for Grants and Contracts. The goal of the intended FOA is to establish a Coordinating Center (CC) for PRS Methods and Analysis for Populations of Diverse Ancestry to provide centralized support, infrastructure, coordination, and data analysis for the program collaboratively generate and refine PRS for populations of diverse ancestry by integrating existing datasets with genomic and phenotype data for a range of complex diseases and traits. Together with PRS Centers (described in a separate FOA), grantees funded under the intended FOA will form a Consortium with the primary objectives of: 1) leveraging genetic diversity to develop methods and improve the applicability of PRS to predict health and disease risk across diverse populations, and for a broad range of health and disease measures; and 2) optimizing the integration of large-scale, harmonized genomic and phenotype data to facilitate collaborative analysis, dissemination of PRS-related data, and development of related methods and resources.

Funding Opportunity RFA-HG-20-001 from the NIH Guide for Grants and Contracts. The goal of the intended FOA is to establish Centers for PRS Methods and Analysis for Populations of Diverse Ancestry to collaboratively generate and refine PRS for populations of diverse ancestry by integrating existing datasets with genomic and phenotype data for a range of complex diseases and traits. Together with a Coordinating Center (described in a separate FOA), grantees funded under the intended FOA will form a Consortium with the primary objectives of: 1) leveraging genetic diversity to develop methods and improve the applicability of PRS to predict health and disease risk across diverse populations, and for a broad range of health and disease measures; and 2) optimizing the integration of large-scale, harmonized genomic and phenotype data to facilitate collaborative analysis, dissemination of PRS-related data, and development of related methods and resources.

Notice NOT-DA-20-043 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-041 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-20-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies.

£37,398 to £44,798: Wellcome Sanger Institute: An exciting opportunity to participate in the enhancement of the Open Targets Genetics Portal through development of new functionality and features. Hinxton, Saffron Walden, Essex